THE PLACENTAL TRANSMISSION OF PETHIDINE
Open Access
- 1 December 1965
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 37 (12), 929-933
- https://doi.org/10.1093/bja/37.12.929
Abstract
Pethidine given intravenously to a pregnant patient began to reach the foetus in measurable quantities within 2 minutes. The level of concentration in cord blood fell exponentially, parallel to, but always lower than, the level in maternal blood. Non-pregnant patients excreted pethidine (in urine) mainly as the demethylated compound, norpethidine; pregnant patients and neonates preferentially excreted pethidine in the unchanged state. Two neonates excreted, respectively, 25 per cent and 40 per cent of a received dose of pethidine in 48 hours. Significantly more pethidine reached the foetus after intravenous than after intramuscular injection. Following intramuscular administration of pethidine to a pregnant patient at term, slightly less than 1 per cent of the dose reached the foetus during the subsequent few hours.Keywords
This publication has 6 references indexed in Scilit:
- Placental Transmission and Neonatal Metabolism of PromazineBritish Journal of Anaesthesia, 1965
- The Mode of Administration of Promazine as a Factor in Determining the Extent of Placental TransmissionBritish Journal of Anaesthesia, 1965
- Estrogen Pharmacology. I. The Influence of Estradiol and Estriol on Hepatic Disposal of Sulfobromophthalein (BSP) in Man*JCI Insight, 1964
- THE EXCRETION OF PETHIDINE AND ITS DERIVATIVESBritish Journal of Pharmacology and Chemotherapy, 1963
- THE PHYSIOLOGICAL DISPOSITION AND FATE OF MEPERIDINE (DEMEROL) IN MAN AND A METHOD FOR ITS ESTIMATION IN PLASMA1955
- THE ABSORPTION, DISTRIBUTION AND EXCRETION OF ISONIPECAINE (DEMEROL)1949